Catherine-Mary retweetledi

Surprising results from the FRAIL-AF trial presented today at#ESC2023.
Switching from VKA to DOAC ➡️ 69% higher rate of bleeding!
Is this because the DOAC most used was rivaroxaban?
Or do frail patients benefit from frequent INR checks & close monitoring?

English
























